Table 3

Results for primary and secondary outcomes for the control and intervention groups

BaselineChange from baseline to 4 months
Control group (n=25)Intervention group (n=21)Control group
(n=25)
Intervention group (n=21)P value
Mean (SD)Mean (SD)Mean (95% CI)Mean (95% CI)
OKS26.9 (6.5)26.7 (6.7)9.8 (7.1 to 12.6)12.1 (9.1 to 15.1)0.27
TUG8.3 (1.7)9.4 (3.6)−0.6 (−1.4 to 0.3)−1.9 (−2.9 to −1.0)0.04
Pain54.2 (21.6)57.1 (18.3)−26.7 (−36.4 to −17.0)−36.3 (−46.7 to −25.8)0.18
10-MWT1.6 (0.3)1.6 (0.4)0.1 (−0.0 to 0.2)0.2 (0.1 to 0.3)0.06
SPPB
 Total9.6 (1.5)9.5 (1.5)0.8 (0.1 to 1.4)1.1 (0.4 to 1.7)0.51
 Balance3.8 (0.5)3.8 (0.5)0.1 (−0.1 to 0.4)−0.2 (−0.4 to 0.1)0.11
 Mobility3.9 (0.3)3.8 (0.8)0.1 (−0.1 to 0.3)0.2 (−0.0 to 0.4)0.64
 LE strength2.0 (1.1)2.0 (1.0)0.5 (0.1 to 1.0)1.1 (0.6 to 1.6)0.12
Muscle force
 Extension1.1 (0.4)1.2 (0.5)−0.1 (−0.2 to 0.0)−0.1 (−0.2 to 0.0)0.85
 Flexion0.6 (0.2)0.6 (0.3)0.1 (−0.0 to 0.1)0.1 (−0.0 to 0.3)0.88
ROM
 Extension6.6 (4.1)7.3 (7.7)0.1 (−2.7 to 2.9)−0.5 (−3.5 to 2.5)0.76
 Flexion107.0 (13.0)107.0 (18.0)−7.0 (−13.0 to -2.0)−1.0 (−8.0 to 5.0)0.17
  • Group mean and SD values at baseline, mean and 95% CI values indicating the within-group change from baseline to the end of the 4-month intervention period, and p values indicating the intergroup change in 4-month intervention.

  • LE, lower extremity; Muscle force, isometric muscle force of the operated lower limb (Nm/weight); 10-MWT, 10 m Walking Test; OKS, Oxford Knee Score ; ROM, range of motion; SPPB, Short Physical Performance Battery; TUG, Timed Up and Go.